The method has been successfully applied to determinations of PABA and PAS in urine and, after alkaline hydrolysis, to determinations of PAI3A in serum that has been deproteinized with acetonitrile. Wkhin-run imprecision of the PABA detenrnnation ranges from 0.8% to 4.2% for urine samples and from 3.9% to 8.2% for serum samples; day-to-day imprecision vanes from 3.2% to 10% for serum samples.
INDEXING TERMS: urine #{149} pancreatic function #{149} bentiromide chymotrypsin Since its introduction in 1976 [1] , the bentiromide test for assessing exocrine pancreatic function has been extensively investigated, both for sensitivity and for specificity [2] [3] [4] . The bentiromide test is based on the specific hydrolysis by pancreatic chymotrypsin of the orally administered synthetic peptide, N-benzoyl-L-tyrosyl-p-aminobenzoic acid (BT-PABA), in the small intestine and measurement of the released p-aminobenzoic acid (PABA) in urine.' The amount of PABA excreted in urine within a specific period is a measure of pancreatic exocrine function.
The specificity of the bentiromide test has been increased by including an internal marker and calculating the PABA excretion index, i.e., the ratio of the excreted PABA to the excreted marker. The most convenient to patients and hospital staff is the 1-day test in which p-aminosalicylic acid (PAS) is the pharmacokinetic marker used to determine the PABA excretion index [5] .
Studies on the determination of PABA in serum have also shown promising results [6, 7] . As reported elsewhere, the BT-PABA test in serum has the same sensitivity and specificity as the urine test [6] . Moreover, serum measurements offer a shorter test procedure by obviating the need for an accurate collection of urine-which is often difficult in children, severely ill patients, and outpatients. However, because PABA concentrations in serum are much lower than those excreted in urine, methods for determining PABA in serum must be very sensitive and specific.
Current procedures for determining PABA in urine or serum include photometry [8, 9] and HPLC [5, 6, 10] . The photometric assay, based on the measurement of urinary arylamines by the Bratton-Marshall reaction [11] , lacks specificity; it is severely affected by various medications, especially antibiotics, analgesics, sulfonamides, and diuretics, and by some food ingredients. Analysis by HPLC is more specific but requires a time-consuming, tedious, and labor-intensive procedure [7] . Moreover, HPLC equipment is complicated to operate, and running costs can be considerable.
main disadvantage of the method is interference from certain endogenous and extraneous compounds through severely overlapping spectra.
Sensitization
of fluorescence of lanthanide ions, especially europium and terbium ions, by organic donor molecules has been studied extensively in recent years, with the aim of developing spectrofluorometric methods for quantifying organic analytes [13, 14] . In this process, the excitation of an organic ligand by the absorbance of light is followed by energy transfer to the excited energy levels of the lanthanide. The use of luminescence reactions that involve the formation of chelates with lanthanide ions is a useful approach to the selective determination of the ligand, because of the typically large Stoke's shift and narrow emission band of these systems.
The enhancement of terbium fluorescence by complexation with several aromatic acids in the presence either of EDTA or tri-n-octylphosphine oxide (TOPO) as synergistic agents has been reported [14] [15] [16] . show very weak fluorescence, which strongly increases in the presence of either PABA or PAS because of the formation of ternary complexes of PABA-Tb-TOPO or PAS-Tb-TOPO (or both). Fig. 1 shows the excitation and emission spectra of PABA-Tb-TOPO and PAS-Tb-TOPO ternary complexes in weakly acidic aqueous solution (pH 5.5). Alkaline (pH = 12.6)
aqueous Tb-EDTA solutions also show a weak fluorescence, which is strongly increased only in the presence of PAS (through the formation of a ternary PAS-Tb-EDTA complex) (Fig. 2) . The intrinsic fluorescence of PABA and PAS under the same conditions is negligible.
The excitation spectra of PABA-Tb-TOPO, PAS-Tb-TOPO, and the PAS-Tb-EDTA ternary complexes are similar to those of PABA and PAS, whereas the emission spectra of the complexes are similar to the emission of terbium ions. We can therefore conclude that PABA and PAS are the common absorbers that then transfer their energy to the lanthanide ions, leading to the fluorescence of the latter.
ASSAY OPTIMIZATION
Taking into account that the expected molar ratios of PABA: PAS in real urine samples are in the range of -1:10 to 1:1, the assay components were optimized in relation to the analytical signal for PABA.
pH. The effect of pH on the PABA-Tb-TOPO system was studied by adjusting the pH of Tb-TOPO-CPCI solution; Fig.  3A shows the resulting variation of fluorescence intensity. The effect of TOPO concentration was studied in the presence of CPC1 necessary for its solubilization.
As Fig. 3C shows, the Interference. Interference from several drugs and other compounds was tested by analyzing urine and serum samples supplemented with PABA and PAS with various amounts of the substances under investigation.
The drugs naproxen, diazepam, sulfamethoxazole, thiamine, lorazepam, acetammnophen (paracetamol), sulfisoxazole, cefatrizine, trimethoprim, and prazepam and benzoic and hippuric acids added to urine samples at a final concentration of 0.1 gIL and subjected to the whole analytical procedure, gave no observable interference in the determinations of PABA and PAS. Fluoroquinolone antibiotics such as norfioxacin, ciprofloxacin, and pefloxacin as well as furosemide caused positive error in the determinations of PABA and PAS. Analogs of PAS, such as salicylic acid and its metabolites (gentisic and salicyluric acid) and diflunisal, caused positive error in the determination of PAS as expected. Therefore, administration of these drugs before the test should be avoided.
DETERMINATION OF PABA AND PAS IN URINE
We performed a detailed study on the effects of the urine matrix as well as the hydrolysis process on the analytical signals for PABA and PAS, using both PABA and PAS working solutions. Among several hydrolysis procedures proposed for PABA and PAS conjugates [3] [4] [5] 12] , we selected alkaline hydrolysis in 4 molJL NaOH with heating for 30 mm at 90 #{176}C [12] , which gives the best results in terms of the completeness of hydrolysis of the conjugates and the stability of PAS during the hydrolysis. Moreover, given our previous experience on the effect of sonication on the rate of hydrolysis of sulfate esters of bile acids /17], we perform the hydrolysis procedure with sonication.
When we found that the rate of the evaporation of acetonitrile after deproteinization of the serum samples increased about twofold under sonication, we used sonication throughout the whole procedure. Figure 4 shows the calibration curves for PABA in aqueous solutions (curve A), in aqueous solutions after addition of sodium hydroxide and acetic acid to simulate the conditions after hydrolysis (curve B), in aqueous solutions after hydrolysis (curve C), and in urine after hydrolysis (curve D). The slopes of are slightly higher than those for aqueous solution and stay practically constant from sample to sample. Thus, we could measure urinary PABA concentration from the calibration curve obtained with hydrolyzed aqueous calibrators, using the blanked signal values for the aqueous calibrators and for the urine samples. Figure 5 shows the results for the same study performed for PAS in PABA working solution. Analytical recovery experiments for PABA and PAS were performed in synthetic mixtures that were prepared in drug-free urine and subjected to the whole analytical procedure. PABA and PAS concentrations were calculated from the calibration curves for PABA and PAS and Eq. 1. The concentrations prepared in the drug-free urine are typical for PABA and PAS excreted for 6 h after a 1000-mg oral dose of bentiromide and 300 mg of PAS [7] . As shown in Table 1 , recoveries in urine were satisfactory, ranging from 97% to 110% for PAS and from 96% to 110% for PABA. Within-run imprecision of the urine assay, measured by analyzing four different urine samples four times each with the whole analytical procedure, varied from 0.8% to 4.2% for PABA and was 5.5% for PAS.
DETERMINATION OF PABA IN SERUM
Analytical recovery experiments for PABA were performed in control (normal) serum supplemented with PABA. Concentrations were calculated from a calibration curve for PABA calibrators in control serum that had been subjected to the whole analytical procedure (deproteinization, hydrolysis, neutralization), as previously described.
The concentrations selected for serum are typical for PABA concentrations 1.5 h after a 1000-mg oral dose of bentiromide /6]. As shown in Table I , 
